June 20, 2021
Business News

AbCellera Reports Q1 2021 Business Results


VANCOUVER, British Columbia–()–AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the first quarter of 2021.

“Our partnership business continued to thrive in the first quarter of 2021, expanding our diversified program portfolio through collaborations with both new and existing partners,” said Carl Hansen, Ph.D., President and CEO of AbCellera. “Royalty revenue from our COVID-19 program continues to provide us with non-dilutive funding, bolstering our strong cash position as we execute on our long-term growth strategies.”

Q1 2021 Business Highlights

  • Earned $203 million in total revenue,…



Click here to view the original article.

Related Posts

You might also like ...

Sonos Prime Day Deals 2021: Early Sonos One Speaker, Beam Soundbar & More Deals Ranked by The Consumer Post
Prime Day LEGO Deals (2021): Early LEGO Star Wars Millennium Falcon, Harry Potter & LEGO Boost Savings Ranked by Spending Lab
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm